prof. MUDr. Miroslav Penka CSc.

Ph(-)myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide

2021 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové